These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 20651397

  • 1. Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience.
    Marino D, Burra P, Boccagni P, Calabrese F, Canova F, Trentin C, Boso C, Soldà C, Angeli P, Aversa SM.
    Anticancer Res; 2010 Jun; 30(6):2383-91. PubMed ID: 20651397
    [Abstract] [Full Text] [Related]

  • 2. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S.
    Transplantation; 2007 Apr 15; 83(7):912-8. PubMed ID: 17460562
    [Abstract] [Full Text] [Related]

  • 3. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 15; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO.
    Clin Transplant; 2013 Jan 15; 27(4):E469-77. PubMed ID: 23758407
    [Abstract] [Full Text] [Related]

  • 5. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK.
    Liver Transpl Surg; 1999 May 15; 5(3):184-91. PubMed ID: 10226108
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 7. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S, Debray D, Delarue A, Deschênes G.
    Pediatr Nephrol; 2002 Aug 15; 17(8):668-72. PubMed ID: 12185479
    [Abstract] [Full Text] [Related]

  • 9. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 20; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 11. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.
    Cornejo A, Bohnenblust M, Harris C, Abrahamian GA.
    Cancer Chemother Pharmacol; 2009 Sep 20; 64(4):857-60. PubMed ID: 19588139
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar 20; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 13. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Mar 20; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 14. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
    Liver Transpl; 2007 Jun 20; 13(6):904-12. PubMed ID: 17539010
    [Abstract] [Full Text] [Related]

  • 15. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
    Taylor AL, Bowles KM, Callaghan CJ, Wimperis JZ, Grant JW, Marcus RE, Bradley JA.
    Transplantation; 2006 Aug 15; 82(3):375-81. PubMed ID: 16906036
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
    Aversa SM, Stragliotto S, Marino D, Calabrese F, Rigotti P, Marchini F, Gambino A, Feltrin G, Boso C, Canova F, Soldà C, Mazzarotto R, Burra P.
    Acta Haematol; 2008 Aug 15; 120(1):36-46. PubMed ID: 18797163
    [Abstract] [Full Text] [Related]

  • 17. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 18. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.
    Hepatogastroenterology; 2000 Jul 15; 47(31):211-9. PubMed ID: 10690611
    [Abstract] [Full Text] [Related]

  • 19. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep 15; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 15; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.